China Universal Asset Management Co., Ltd. Arcellx, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,021 shares of ACLX stock, worth $785,907. This represents 0.07% of its overall portfolio holdings.
Number of Shares
11,021
Previous 11,466
3.88%
Holding current value
$785,907
Previous $873,000
17.3%
% of portfolio
0.07%
Previous 0.08%
Shares
15 transactions
Others Institutions Holding ACLX
# of Institutions
211Shares Held
48.7MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$320 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$284 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$267 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$251 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$217 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.12B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...